Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD 2014)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: Updated 2014Global Initiative for Chronic Obstructive Lung Disease2014 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014.pdfAccessed June 18, 2014
   Google Scholar
• National Institute for Health and Care ExcellenceNICE Guidelines [CG101]: Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care (Partial Update)LondonNational Institute for Health and Care Excellence2010 Available from: http://www.nice.org.uk/guidance/CG101Accessed June 18, 2014
   Google Scholar
• CazzolaMMateraMGLong-acting bronchodilators are the first-choice option for the treatment of stable COPDChest2004125191114718412
   PubMed Web of Science ®Google Scholar
• VogelmeierCKardosPHarariSGansSJStengleinSThirlwellJFormoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month studyRespir Med2008102111511152018804362
   PubMed Web of Science ®Google Scholar
• Van NoordJAAumannJLJanssensECombining tiotropium and salmeterol in COPD: effects on airflow obstruction and symptomsRespir Med20101047995100420303247
   PubMed Web of Science ®Google Scholar
• MahlerDAD’UrzoABatemanEDConcurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonThorax201267978178822544891
   PubMed Web of Science ®Google Scholar
• BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J20134261484149423722616
   PubMed Web of Science ®Google Scholar
• AntónEHow and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?Expert Rev Respir Med20137Suppl 2253223551021
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMA new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)Prim Care Respir J201322111712123443227
   PubMedGoogle Scholar
• PostmaDSCalverleyPInhaled corticosteroids in COPD: a case in favourEur Respir J2009341101219567598
   PubMed Web of Science ®Google Scholar
• SuissaSBarnesPJInhaled corticosteroids in COPD: the case againstEur Respir J2009341131619567599
   PubMed Web of Science ®Google Scholar
• PriceDYawnBBrusselleGRossiARisk-to-benefit ratio of inhaled corticosteroids in patients with COPDPrim Care Respir J20132219210023135217
   PubMedGoogle Scholar
• NanniniLJLassersonTJPoolePCombined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20129CD00682922972099
   PubMed Web of Science ®Google Scholar
• CrimCCalverleyPMAndersonJAPneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEur Respir J200934364164719443528
   PubMed Web of Science ®Google Scholar
• SuissaSAuthor’s response to letter on number needed to treat in COPD: exacerbations versus pneumoniasThorax201368988288323935172
   PubMed Web of Science ®Google Scholar
• KimJHParkJSKimKHJeongHCKimEKLeeJHInhaled corticosteroid is associated with an increased risk of TB in patients with COPDChest201314341018102423079688
   PubMed Web of Science ®Google Scholar
• CorradoARossiAHow far is real life from COPD therapy guidelines? An Italian observational studyRespir Med2012106798999722483189
   PubMed Web of Science ®Google Scholar
• FitchKIwasakiKPyensonBPlauschinatCZhangJVariation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysisCurr Med Res Opin20112771425142921599554
   PubMed Web of Science ®Google Scholar
• JebrakGCOPD routine management in France: are guidelines used in clinical practice?Rev Mal Respir20102711118 French [with English abstract]20146947
   PubMed Web of Science ®Google Scholar
• JochmannANeubauerFMiedingerDGeneral practitioners’ adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort StudySwiss Med Wkly Epub4212010
   Web of Science ®Google Scholar
• JonesRCDickson-SpillmannMMatherMJMarksDShackellBSAccuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care auditRespir Res200896218710575
   PubMed Web of Science ®Google Scholar
• LucasAESmeenkFWSmeeleIJvan SchayckCPOvertreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory studyFam Pract2008252869118304973
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD 2007)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: Updated December 2007Global Initiative for Chronic Obstructive Lung Disease2007 Available from: http://www.goldcopd.org/uploads/users/files/GOLDReport07_0108.pdfAccessed June 18, 2014
   Google Scholar
• British Medical Association2014/15 General Medical Services (GMS) Contract Quality and Outcomes Framework (QOF)LondonBritish Medical Association2014 Available from: http://bma.org.uk/practical-support-at-work/contracts/independent-contractors/qof-guidanceAccessed June 18, 2014
   Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD 2013)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: Updated 2013Global Initiative for Chronic Obstructive Lung Disease2013 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdfAccessed June 18, 2014
   Google Scholar
• HillSCMillerGESingMAdults with diagnosed and untreated diabetes: who are they? How can we reach them?J Health Care Poor Underserved20112241221123822080705
   PubMed Web of Science ®Google Scholar
• AvasaralaJRO’DonovanCARoachSECamachoFFeldmanSRAnalysis of NAMCS data for multiple sclerosis, 1998–2004BMC Med20075617411425
   PubMed Web of Science ®Google Scholar
• GavrasHPIssues in hypertension: drug tolerability and special populationsAm J Hypertens2001147 Pt 2231S236S11459211
   PubMed Web of Science ®Google Scholar
• Harris InteractiveMany Who Suffer From Multiple Sclerosis (MS) Are Not Getting Treatment They Could Benefit From2001 Available from: http://www.mult-sclerosis.org/news/May2001/HarrisPollPwMSundertreated.htmlAccessed June 18, 2014
   Google Scholar
• WongNDLopezVAL’ItalienGChenRKlineSEFranklinSSInadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003–2004Arch Intern Med2007167222431243618071164
   PubMedGoogle Scholar
• FranssenFMSpruitMAWoutersEFDeterminants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011649350122069360
   PubMed Web of Science ®Google Scholar
• SmallMBroomfieldSHigginsVQuantification and treatment patterns of real-world patients classified by the GOLD 2011 strategyPoster presented at: 22nd Annual Congress of the European Respiratory SocietySeptember 1–5, 2012Vienna, Austria
   Google Scholar
• DecramerMBartschPPauwelsRYernaultJCManagement of COPD according to guidelines. A national survey among Belgian physiciansMonaldi Arch Chest Dis2003591628014533285
   PubMedGoogle Scholar
• GlaabTBanikNRutschmannOTWenckerMNational survey of guideline-compliant COPD management among pneumologists and primary care physiciansCOPD20063314114817240616
   PubMedGoogle Scholar
• MiravitllesMBrosaMVelascoMAn economic analysis of pharmacological treatment of COPD in SpainRespir Med2009103571472119168340
   PubMed Web of Science ®Google Scholar
• MiravitllesMAndreuIRomeroYSitjarSAltésAAntonEDifficulties in differential diagnosis of COPD and asthma in primary careBr J Gen Pract201262595e68e7522520766
   PubMed Web of Science ®Google Scholar
• PerezXWisniveskyJPLurslurchachaiLKleinmanLCKronishIMBarriers to adherence to COPD guidelines among primary care providersRespir Med2012106337438122000501
   PubMed Web of Science ®Google Scholar
• SalinasGDWilliamsonJCKalhanRBarriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physiciansInt J Chron Obstruct Pulmon Dis2011617117921468169
   PubMed Web of Science ®Google Scholar
• PearsonMAyresJGSarnoMMasseyDPriceDDiagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997–2001Int J Chron Obstruct Pulmon Dis20061443544318044099
   PubMedGoogle Scholar
• WhitePThorntonHPinnockHGeorgopoulouSBoothHPOvertreatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational studyPLoS One2013810e7522124194824
   PubMed Web of Science ®Google Scholar
• BrusascoVHodderRMiravitllesMKorduckiLTowseLKestenSHealth outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax200358539940412728159
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J200219221722411866001
   PubMed Web of Science ®Google Scholar
• DonohueJFvan NoordJABatemanEDA 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolChest20021221475512114338
   PubMed Web of Science ®Google Scholar
• DonohueJFKalbergCEmmettAMerchantKKnobilKA short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPDTreat Respir Med20043317318115219176
   PubMedGoogle Scholar
• WilsonIDepression in the patient with COPDInt J Chron Obstruct Pulmon Dis200611616418046903
   PubMedGoogle Scholar
• AgustiAHurdSJonesPFAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohortsEur Respir J20134251391140123645406
   PubMed Web of Science ®Google Scholar
• BednarekMMaciejewskiJWozniakMKucaPZielinskiJPrevalence, severity and underdiagnosis of COPD in the primary care settingThorax200863540240718234906
   PubMed Web of Science ®Google Scholar
• MapelDWDalalAABlanchetteCMPetersenHFergusonGTSeverity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claimsInt J Chron Obstruct Pulmon Dis2011657358122135490
   PubMed Web of Science ®Google Scholar
• SorianoJBZielinskiJPriceDScreening for and early detection of chronic obstructive pulmonary diseaseLancet2009374969172173219716965
   PubMed Web of Science ®Google Scholar
• HaughneyJGruffydd-JonesKRobertsJLeeAJHardwellAMcGarveyLThe distribution of COPD in UK general practice using the new GOLD classificationEur Respir J2014434993100224176990
   PubMed Web of Science ®Google Scholar
• JonesRCPriceDRyanDOpportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortLancet Respir Med20142426727624717623
   PubMed Web of Science ®Google Scholar